Potential Drug Targets and Biomarkers for IGHV1-12 (G28471)

Target Name: IGHV1-12

NCBI ID: G28471

IGHV1-12

Other Name(s): immunoglobulin heavy variable 1-12 (pseudogene) | IGHV112 | Immunoglobulin heavy variable 1-12 (pseudogene) | 1-12P

Potential Drug Targets and Biomarkers for IGHV1-12

IGHV1-12 (Immunoglobulin Heavy Variable 1-12), also known as pseudogene, is a gene that encodes a protein known as immunoglobulin heavy variable 1-12 (IgHV1-12). This protein plays a critical role in the immune system , specifically in the regulation of inflammation and autoimmune diseases. As a result, IGHV1-12 has been identified as a potential drug target and biomarker for a variety of diseases.

The IGHV1-12 protein is a member of the IgH family of proteins, which are known for their role in providing the body with immunity. IgHV1-12 is a type of IgH protein that is expressed in many different tissues throughout the body, including the liver, spleen, and lymph nodes. It is also expressed in the bloodstream, where it plays a crucial role in the immune response.

One of the key functions of IGHV1-12 is its role in regulating inflammation. When the body is exposed to an infection or other harmful substance, IGHV1-12 is among the first proteins to be produced in response. It helps to recruit other immune cells to the site of injury or infection, where it can help to neutralize the invading substance and prevent further damage.

IGHV1-12 is also involved in the regulation of autoimmune diseases. These are diseases in which the body attacks itself, leading to inflammation and damage to various tissues. IGHV1-12 has been shown to play a key role in the development and progression of autoimmune diseases. For example, studies have shown that people with rheumatoid arthritis, an autoimmune disease, have lower levels of IGHV1-12 than those without the disease.

In addition to its role in inflammation and autoimmune diseases, IGHV1-12 has also been shown to have a variety of other functions. For example, it has been shown to play a role in the regulation of cell growth and differentiation, and it has been shown to interact with a variety of different signaling pathways.

As a result of its involvement in so many different functions, IGHV1-12 has been identified as a potential drug target and biomarker for a variety of diseases. For example, studies have shown that drugs that target IGHV1-12 have the potential to treat a range of autoimmune diseases, including rheumatoid arthritis, lupus, and multiple sclerosis. In addition, IGHV1-12 has also been shown to be a potential biomarker for diseases such as cancer, and it has been used as a diagnostic marker for a variety of diseases.

Overall, IGHV1-12 is a gene that has the potential to revolutionize our understanding of the immune system and the development of new treatments for a variety of diseases. As more research is conducted on IGHV1-12 and its role in the immune system, it is likely that the number of potential drug targets and biomarkers for this gene will continue to grow.

Protein Name: Immunoglobulin Heavy Variable 1-12 (pseudogene)

The "IGHV1-12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV1-12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets